| Issue | Title | |
| Vol 8, No 1 (2022) | Enfortumab vedotin for the treatment of patients with urothelial cancer after failure of the treatment with PD-1/PD-L1 inhibitor—cost-effectiveness analysis | Abstract PDF (Bulgarian) |
| Toni Vekov, Makreta Draganova, Nadia Veleva, Elena Daracheva, Valentina Belcheva, Jivko Kolev | ||
| Vol 8, No 1 (2022) | Role of angiotensin-converting enzyme inhibitors in patients with aortic stenosis | Abstract PDF (Bulgarian) |
| Stefan Yambolov, Rozen Grigorov | ||
| Vol 9, No 1 (2023) | Role of the hospital pharmacist in preventing drug interactions in clinical practice | Abstract PDF (Bulgarian) |
| Maya Radeva-Ilieva | ||
| Vol 9, No 1 (2023) | A review of cancer immunotherapy: immune checkpoint inhibitors | Abstract PDF (Bulgarian) |
| Maya Radeva-Ilieva | ||
| Vol 10, No 1 (2024) | Overview of the historical development and analysis of the stages of introduction of clinical pharmacy in Bulgaria | Abstract PDF (Bulgarian) |
| Savina Elitova, Ilko Getov | ||
| Vol 10, No 1 (2024) | Review of the economic burden of metastatic prostate cancer | Abstract PDF (Bulgarian) |
| Konstantin Ivanov, Hristina Lebanova | ||
| Vol 10, No 1 (2024) | Reimbursement of biomarkers in oncology: advantages and economic analysis of their application for diagnostics as part of the personalized medicine аpproach | Abstract PDF (Bulgarian) |
| Veneta Todorova, Emilia Krapcheva, Georgi Slavchev, Slaveyko Dzhambazov, Toni Vekov | ||
| Vol 10, No 1 (2024) | A review of the fundamental principles for personalized pharmacotherapy prescribing for patients with concurrent renal and cardiac failure: the hospital pharmacist’s perspective | Abstract PDF (Bulgarian) |
| Svetoslav Stoev, Hristina Lebanova | ||
| Vol 11, No 1 (2025) | Assisted reproduction and increased risk for mother and child | Abstract PDF (Bulgarian) |
| Ivaneta Yoncheva-Biserova, Hristina Nocheva, Mariana Yoncheva-Mihaylova | ||
| Vol 11, No 1 (2025) | Access to targeted therapy for prostate cancer in Bulgaria | Abstract PDF (Bulgarian) |
| Konstantin Ivanov, Nadia Veleva, Hristina Lebanova | ||
| Vol 11, No 1 (2025) | Training needs and thematic preferences of hospital pharmacists in Bulgaria: results from the 2025 survey of the Bulgarian Association of Hospital and Clinical Pharmacists (BAHCP) | Abstract PDF (Bulgarian) |
| Mariya lieva, Velina Grigorova, Natalia Kokudeva, Nadezda Grigorova, Tatiana Petrova, Reni Vatkova, Petаr Kavlakov | ||
| Vol 11, No 1 (2025) | Development and establishment of the clinical role of the hospital pharmacist in multidisciplinary teams at the European level | Abstract PDF (Bulgarian) |
| Tsvetelina Stefanova, Evgeni Grigorov, Galina Petrova | ||
| Vol 11, No 1 (2025) | Pharmacotherapy in patients with acute and exacerbated chronic pyelonephritis | Abstract PDF (Bulgarian) |
| Nedyalko Grigorov, Todor Naydenov, Emine Kalvicheva, Stanislava Barakova | ||
| Vol 12, No 1 (2026) | Innovative surgical techniques for malignant diseases of the gastrointestinal tract | Abstract PDF (Bulgarian) |
| Kostadin Angelov | ||
| Vol 12, No 1 (2026) | Role of pharmacogenomics in the drug development process | Abstract PDF (Bulgarian) |
| Stanislav Tsankov, Toni Vekov, Valentina Belcheva, Evgeni Grigorov | ||
| Vol 12, No 1 (2026) | A review of IoT solutions for temperature and humidity monitoring during the transport of pharmaceutical products | Abstract PDF (Bulgarian) |
| Polina Mihova, Todor Dachev, Georgi Petrov, Margarita Koteva | ||
| Vol 12, No 1 (2026) | Analysis of the mortality from malignant hematological neoplasms in Bulgaria (2019–2025) and perspectives for the development of clinical pharmacy services | Abstract PDF (Bulgarian) |
| Tsvetelina Stefanova, Evgeni Grigorov, Galina Petrova | ||
| Vol 12, No 1 (2026) | Regulatory framework for artificial intelligence in Bulgaria and its significance for hospital pharmacy | Abstract PDF (Bulgarian) |
| Simona Belcheva, Hristina Lebanova | ||
| Vol 12, No 1 (2026) | New therapeutic directions in multiple sclerosis: from early high-efficacy immunotherapy to targeting progression, remyelination, and personalized medicine | Abstract PDF (Bulgarian) |
| Paulina Ilieva, Ivan Milanov, Evgeni Grigorov, Orlin Nedev | ||
| Vol 2, No 1 (2016) | A clinical audit of sterile medical devices: A french experience of quality and safety improvement in hospital services | Abstract PDF |
| Valeria Vinciguerra, Annie Fagot-Gandet, Cyril Boronad | ||
| Vol 9, No 1 (2023) | Advancements in Malaria Pharmacotherapy in the Modern Period and the 21st Century | Abstract PDF (Bulgarian) |
| Alexander Zlatanov, Antoniya Yanakieva | ||
| Vol 1, No 1 (2015) | Aim and Mission | Abstract PDF |
| Editorial Team | ||
| Vol 7, No 1 (2021) | Analysis of marketing authorization procedures with negative opinion 2020-2021 – how EMA handled challenges in drug therapy during Covid-19 pandemic | Abstract PDF |
| Violeta Getova, Ilko Getov | ||
| Vol 8, No 1 (2022) | Analysis of the centralized preparation of medicines for systemic treatment of malignant diseases in nine European countries | Abstract PDF (Bulgarian) |
| Velina Grigorova, Evgeni Grigorov | ||
| Vol 7, No 1 (2021) | Analysis of the cost-effectiveness of three-component therapies with daratumumab for the treatment of patients with recurrent refractory multiple myeloma | Abstract PDF |
| T. Vekov, H. Lebanova, N. Veleva, V. Belcheva, J. Kolev, M Vlahova | ||
| 1 - 25 of 124 Items | 1 2 3 4 5 > >> | |